Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Abracadabra!

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Nov 23, 2022 8:56am

147 Views

Post# 35121196

RE:RE:RE:Abracadabra!

TitanBrawler wrote: Another moron sitting by his computer waiting for anyone who bashes this dog sh*t .
Keep averaging down, so you can look at your worthless shares . And reflect on the wasted years and your dead money.
Lol.

Stupid dog... abracadabra do I use the ignore button.... no I will read your stupidities, I have nothing esles to do dummy.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario